中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2013年
30期
36-37
,共2页
美托洛尔%慢性充血性心力衰竭
美託洛爾%慢性充血性心力衰竭
미탁락이%만성충혈성심력쇠갈
Metoprolol%Chronic congestive heart failure
目的：探讨美托洛尔治疗慢性充血性心力衰竭（CHF）的临床疗效，为临床实践提供参考依据。方法：120例慢性充血性心力衰竭患者随机平均分为治疗组和对照组，对照组给予常规抗心衰治疗，治疗组在对照组治疗的基础上加用美托洛尔治疗，治疗6个月后，比较两组患者的心功能和左室射血分数的改善情况。结果：治疗后，治疗组总有效率及显效率均明显高于对照组，左室射血分数显著升高，差异有统计学意义（P<0.05）。结论：在常规抗心力衰竭药物治疗基础上加用美托洛尔能够显著改善CHF患者的心功能和左室射血分数，且安全性较好，值得临床推广应用。
目的：探討美託洛爾治療慢性充血性心力衰竭（CHF）的臨床療效，為臨床實踐提供參攷依據。方法：120例慢性充血性心力衰竭患者隨機平均分為治療組和對照組，對照組給予常規抗心衰治療，治療組在對照組治療的基礎上加用美託洛爾治療，治療6箇月後，比較兩組患者的心功能和左室射血分數的改善情況。結果：治療後，治療組總有效率及顯效率均明顯高于對照組，左室射血分數顯著升高，差異有統計學意義（P<0.05）。結論：在常規抗心力衰竭藥物治療基礎上加用美託洛爾能夠顯著改善CHF患者的心功能和左室射血分數，且安全性較好，值得臨床推廣應用。
목적：탐토미탁락이치료만성충혈성심력쇠갈（CHF）적림상료효，위림상실천제공삼고의거。방법：120례만성충혈성심력쇠갈환자수궤평균분위치료조화대조조，대조조급여상규항심쇠치료，치료조재대조조치료적기출상가용미탁락이치료，치료6개월후，비교량조환자적심공능화좌실사혈분수적개선정황。결과：치료후，치료조총유효솔급현효솔균명현고우대조조，좌실사혈분수현저승고，차이유통계학의의（P<0.05）。결론：재상규항심력쇠갈약물치료기출상가용미탁락이능구현저개선CHF환자적심공능화좌실사혈분수，차안전성교호，치득림상추엄응용。
Objective:To observe the therapeutic efficacy of metoprolol in the treatment of chronic congestive heart failure,and provide information for clinical practice. Method:120 patients with chronic congestive heart failure were randomly divided into the observation group and control group. The routine cardiotonic and diuretic were used in both groups,besides this,the observation group was added with metoprolol for six months. The improvement of heart function and left ejection fraction were compared. Result:Both the total effective rate and excellence effective rate in the observation group were higher than those in the control group,with a significant difference between them(P<0.05),and the left ejection fraction increased significantly. Conclusion:Using metoprolol on the basis of the routine treatment of cardiotonic and diuretic for chronic heart failure can effectively improve the heart function and left ejection fraction,and its clinical effect is definite and safe.
